Innate Pharma SA anounces that it has received approval from the French authorities to start an exploratory Phase II clinical trial in chronic myeloid leukemia ("CML") with IPH 1101.
| PR in english | 86.69 KB |
| CP en français | 90.96 KB |
Innate Pharma SA anounces that it has received approval from the French authorities to start an exploratory Phase II clinical trial in chronic myeloid leukemia ("CML") with IPH 1101.
| PR in english | 86.69 KB |
| CP en français | 90.96 KB |